ES2323627A1 - Procedure for obtaining a product for the manufacture of plan tillas, ortesis and prótesis for foot and footwear (Machine-translation by Google Translate, not legally binding) - Google Patents

Procedure for obtaining a product for the manufacture of plan tillas, ortesis and prótesis for foot and footwear (Machine-translation by Google Translate, not legally binding) Download PDF

Info

Publication number
ES2323627A1
ES2323627A1 ES200703233A ES200703233A ES2323627A1 ES 2323627 A1 ES2323627 A1 ES 2323627A1 ES 200703233 A ES200703233 A ES 200703233A ES 200703233 A ES200703233 A ES 200703233A ES 2323627 A1 ES2323627 A1 ES 2323627A1
Authority
ES
Spain
Prior art keywords
product
manufacture
footwear
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200703233A
Other languages
Spanish (es)
Other versions
ES2323627B1 (en
Inventor
Angel Camp Fauli
Ricardo Espasa Vidallach
Andres Molla Chico De Guzman
Cesar Orgiles Barcelo
Pascual Martinez Ibañez
Enrique Montiel Parreño
Norberto Porta Rosas
Cristina Llobel Andres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomech Consulting Sl
Original Assignee
Todo Para Sus Pies S L
TODO PARA SUS PIES SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Todo Para Sus Pies S L, TODO PARA SUS PIES SL filed Critical Todo Para Sus Pies S L
Priority to ES200703233A priority Critical patent/ES2323627B1/en
Publication of ES2323627A1 publication Critical patent/ES2323627A1/en
Application granted granted Critical
Publication of ES2323627B1 publication Critical patent/ES2323627B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B17/00—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined
    • A43B17/14—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined made of sponge, rubber, or plastic materials
    • A—HUMAN NECESSITIES
    • A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
    • A47B—TABLES; DESKS; OFFICE FURNITURE; CABINETS; DRAWERS; GENERAL DETAILS OF FURNITURE
    • A47B17/00—Writing-tables
    • A47B17/003—Writing-tables made of metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/01—Orthopaedic devices, e.g. splints, casts or braces
    • A61F5/14—Special medical insertions for shoes for flat-feet, club-feet or the like
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nursing (AREA)
  • Manufacturing & Machinery (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)

Abstract

Procedure for obtaining a product for the manufacture of insoles, orthoses and prostheses for feet and footwear. The procedure is based on the fact that the product to manufacture insoles, orthoses and prostheses for feet and footwear, is obtained from the mixture of two pre-dosed components and packaged in unitary single-use containers, preferably predosing the two monocomponents of polyurethane, such as polyol and isocyanate, as raw material normally used for the manufacture of insoles, orthoses and prostheses for feet and footwear. The pre-packaged monodose can incorporate additives that confer specific characteristics for each treatment, such as healing, antiseptic, fungicides, refreshing, soothing, stimulating and moisturizing. (Machine-translation by Google Translate, not legally binding)

Description

Procedimiento de obtención de un producto para la fabricación de plantillas, ortesis y prótesis para pies y calzados.Procedure for obtaining a product for the manufacture of insoles, orthotics and prostheses for feet and footwear

Objeto de la invenciónObject of the invention

La presente invención, según se expresa en el enunciado de esta memoria descriptiva, se refiere a un procedimiento de obtención de un producto para la fabricación de plantillas, ortesis y prótesis para pies y calzados, basado en establecer una previa dosificación exacta de los componentes que intervienen en la mezcla o producto del que se obtendrá la plantilla, ortesis o prótesis, que se pretende.The present invention, as expressed in the set forth in this specification, refers to a procedure for obtaining a product for the manufacture of insoles, orthotics and prostheses for feet and footwear, based on establish an exact previous dosage of the components that they intervene in the mixture or product from which the template, brace or prosthesis, which is intended.

El objeto de la invención es provisionar al profesional de dosis unitarias con la composición específica necesaria de cada uno de los componentes del poliuretano, como producto para la materialización o conformado de la correspondiente plantilla, ortesis o prótesis.The object of the invention is to provision the unit dose professional with specific composition required of each of the polyurethane components, such as product for the materialization or shaping of the corresponding template, brace or prosthesis.

El procedimiento encuentra especial aplicación en el campo o sector de la ortopedia y de los profesionales de la podología.The procedure finds special application in the field or sector of orthopedics and professionals chiropody.

Antecedentes de la invenciónBackground of the invention

En la fabricación de plantillas, ortesis y prótesis, a base de poliuretano, se parte del pesaje por el podólogo u otro profesional de los componentes (poliol e isocianato) cuya mezcla y correspondiente reacción de éstos permite obtener el producto de poliuretano, a partir del cual se moldea la plantilla, ortesis o prótesis.In the manufacture of templates, orthotics and prosthesis, based on polyurethane, is part of the weighing by the podiatrist or other component professional (polyol e isocyanate) whose mixture and corresponding reaction of these allows  obtain the polyurethane product, from which the template, brace or prosthesis.

Los referidos componentes se comercializan en envases o botellas de volumen variable, superior al de la dosis necesaria de cada componente, de manera que el ortopeda o profesional correspondiente debe verter en el molde una cantidad definida de cada uno de dichos componentes, de acuerdo con unos parámetros técnicos definidos para cada paciente. Por lo tanto, es necesario elegir las cantidades que el ortopeda o profesional considera como más adecuadas para componer la formulación de cada una de las plantillas, ortesis o prótesis a conformar.The referred components are marketed in containers or bottles of variable volume, higher than the dose necessary for each component, so that the orthopedic or corresponding professional must pour an amount into the mold defined of each one of said components, according to some technical parameters defined for each patient. Therefore it is necessary to choose the amounts that the orthopedic or professional considered as more appropriate to compose the formulation of each one of the templates, braces or prostheses to be shaped.

Esto supone que es responsabilidad del ortopeda o profesional acertar con la dosis, lo que en ocasiones no es fácil, llevando consigo que a veces los resultados no sean los deseados, ya que con variaciones de tan sólo el 2-3% en la dosificación de alguno de dichos componentes, se pueda obtener un producto de efectos negativos, y con ello una plantilla, ortesis o prótesis, que carece de efectividad.This assumes that it is the responsibility of the orthopedic or professional get the dose right, which sometimes is not easy, taking with it that sometimes the results are not the desired, since with variations of only 2-3% in the dosage of any of these components, it can be obtain a product of negative effects, and with it a template, orthosis or prosthesis, which lacks effectiveness.

Evidentemente, el fabricante de poliuretano aconseja o indica los pesos que de ambos componentes se deben adicionar para formar la mezcla y, como se decía con anterioridad, mínimas variaciones implican cambios sustanciales de las propiedades del poliuretano, pues a pesar de que el profesional selecciona cuidadosamente los tipos de material a utilizar para corregir la patología a tratar, y teniendo en cuenta que la plantilla es un elemento fundamental para el tratamiento o corrección de una anomalía del pie, más allá del confort, un inadecuado control puede provocar un mal tratamiento.Obviously, the manufacturer of polyurethane advises or indicates the weights of both components due add to form the mixture and, as previously stated, minimal variations imply substantial changes in properties of polyurethane, because although the professional selects carefully the types of material to use to correct the pathology to be treated, and considering that the template is a fundamental element for the treatment or correction of a foot abnormality, beyond comfort, inadequate control may cause a bad treatment.

Descripción de la invenciónDescription of the invention

El procedimiento objeto de la invención se basa en intentar evitar que por una inadecuada manipulación en la pesada de los componentes, las propiedades del producto obtenido dejen de tener su función.The process object of the invention is based in trying to avoid that due to improper handling in the heavy components, the properties of the product obtained Stop having your function.

Más concretamente, el procedimiento de obtención de un producto para la fabricación de plantillas, ortesis y prótesis del tipo de las que se obtienen a partir de una mezcla de poliol e isocianato, como componentes del poliuretano, presenta la particularidad de que dichos dos componentes se mezclan a partir de cantidades dosificadas unitariamente en envases de un solo uso; es decir, que los componentes son pre-dosificados y envasados independientemente en envases unitarios.More specifically, the procedure for obtaining of a product for the manufacture of templates, orthotics and prostheses of the type obtained from a mixture of polyol and isocyanate, as components of polyurethane, presents the particularity that said two components are mixed from unit dose quantities in single-use containers; is say that the components are pre-dosed and packaged independently in unit packages.

Por otra parte, y como otra característica del procedimiento, cabe destacar el hecho de que, al menos, uno de esos componentes incorpora diferentes aditivos que confieren características específicas para cada tratamiento.On the other hand, and as another characteristic of procedure, it should be noted that at least one of those components incorporates different additives that confer specific characteristics for each treatment.

Asimismo, es característico el hecho de que cada uno de los envases contenedores de los componentes, presenta una codificación con un color diferente para poder distinguir el tipo de aditivo que incorpora, lo cual indicará al profesional el componente a utilizar de acuerdo con el tipo de tratamiento a prescribir, y por lo tanto el tipo de plantilla a fabricar.Likewise, the fact that each one of the container containers of the components, presents a coding with a different color to distinguish the type of additive that incorporates, which will indicate to the professional the component to be used according to the type of treatment to prescribe, and therefore the type of template to be manufactured.

En la obtención del producto se puede utilizar poliuretano monocomponente, bicomponente, poliéster, poliéter, e incluso con otros polímeros donde la dosificación sea fundamental y se establezcan dosis exactas envasadas en envases independientes y de un solo uso.In obtaining the product can be used monocomponent polyurethane, bicomponent, polyester, polyether, e even with other polymers where the dosage is essential and exact doses packaged in separate containers are established and single use only.

En cuanto a los aditivos que se pueden incorporar en las monodosis pre-envasadas y dosificadas, pueden citarse lo siguientes:As for the additives that can be incorporate in pre-packaged pods and dosed, the following may be cited:

--
Cicatrizantes: como aceite esencial de lavanda, dirigidas a los pies diabéticos y/o sensibles.Scars: as an essential oil of Lavender, aimed at diabetic and / or sensitive feet.

--
Antisépticos y fungicidas: como el aceite esencial del árbol de té, para la prevención de infecciones.Antiseptics and fungicides: such as essential oil of the tea tree, for the prevention of infections

--
Calmantes y relajantes: como el aceite esencial de salvia, pensado para el calzado deportivo y de estar por casa.Soothing and relaxing: like oil essential sage, designed for sports shoes and to be at home.

--
Estimulantes: para activar la circulación.Stimulants: to activate the circulation.

--
Hidratantes: como la urea, el panthenol y bisabolol, la glicerina y aceites naturales hidratantes dirigidas a atenuar la sequedad y/o grietas de los pies.Moisturizers: such as urea, panthenol and bisabolol, glycerin and natural moisturizing oils aimed at attenuating dryness and / or cracks of the feet.

Las plantillas, ortesis y prótesis, que se pueden fabricar con el producto obtenido de acuerdo con el procedimiento de la invención, pueden ser:The insoles, braces and prostheses, which are can be manufactured with the product obtained in accordance with the Process of the invention, can be:

--
Plantillas, ortesis y prótesis, realizadas con sistemas de monodosis de poliuretano bicomponente.Insoles, orthotics and prostheses, made with single-dose polyurethane systems bicomponent

--
Plantillas, ortesis y prótesis, realizadas con sistema de monodosis de poliuretano bicomponente con propiedades cosméticas, teniendo en cuenta que los aditivos serán incorporados preferentemente dentro del componente de poliol.Insoles, orthotics and prostheses, made with two-component polyurethane single-dose system with cosmetic properties, taking into account that the additives will preferably be incorporated into the component of polyol

--
Plantillas, ortesis y prótesis, realizadas con otros polímeros con monodosis o no.Insoles, orthotics and prostheses, made with other polymers with single dose or not.

--
Formas realizadas con sistema de monodosis de poliuretano bicomponente.Shapes made with polyurethane single dose system bicomponent

--
Desmoldeante para el secado de horma.Release agent for drying last.

Finalmente, en cuanto a las ventajas derivadas del procedimiento de la invención, pueden citarse como más importantes las siguientes:Finally, regarding the advantages derived of the process of the invention, can be cited as more important the following:

1.- Se asegura una dosificación exacta de poliuretano reactivo, garantizando con ello propiedades del producto final.1.- An exact dosage of reactive polyurethane, thereby guaranteeing properties of the Final product.

2.- No requiere efectuar pesadas de los componentes, evitando posibles errores en la manipulación.2.- It does not require weighing of the components, avoiding possible handling errors.

3.- Óptimas propiedades físicas referentes a la viscosidad y similares.3.- Optimal physical properties referring to the viscosity and the like.

4.- Facilidad, rapidez y limpieza en el manejo de los componentes, al estar contenidos en envases monodosis.4.- Ease, speed and cleanliness in handling of the components, being contained in single-dose containers.

5.- Se evita el almacenamiento de productos químicos abiertos, por lo que se protegen las personas expuestas.5.- The storage of products is avoided open chemicals, so people protect themselves exposed.

6.- Resistencia a la degradación de los componentes por la acción del ambiente, ya que el envase unitario que los contiene se abre en el momento de ser utilizado.6.- Resistance to degradation of components by the action of the environment, since the unit packaging which contains them opens at the time of use.

Claims (4)

1. Procedimiento de obtención de un producto para la fabricación de plantillas, ortesis y prótesis para pies y calzados, en donde el producto se conforma a partir de la mezcla de un material polimérico bicomponente, preferentemente poliuretano, compuesto a su vez por dos componentes esenciales como son el poliol y el isocianato, caracterizado porque dichos componentes del poliuretano se mezclan a partir de cantidades dosificadas unitariamente en envases de un solo uso.1. Procedure for obtaining a product for the manufacture of insoles, orthotics and prostheses for feet and footwear, where the product is formed from the mixture of a two-component polymeric material, preferably polyurethane, composed of two essential components such as polyol and isocyanate, characterized in that said polyurethane components are mixed from unit dose quantities in single-use containers. 2. Procedimiento de obtención de un producto para la fabricación de plantillas, ortesis y prótesis para pies y calzados, según reivindicación 1, caracterizado porque se añaden en, al menos, alguno de los componentes del poliuretano, diferentes aditivos que confieren características específicas para cada tratamiento.2. Procedure for obtaining a product for the manufacture of insoles, orthotics and prostheses for feet and footwear, according to claim 1, characterized in that at least some of the components of the polyurethane are added, different additives that confer specific characteristics for each treatment. 3. Procedimiento de obtención de un producto para la fabricación de plantillas, ortesis y prótesis para pies y calzados, según reivindicaciones anteriores, caracterizado porque cada uno de los envases de un solo uso se codifica de forma diferente con el fin de distinguir el tipo de aditivo que posee, indicando al profesional el componente a utilizar según el tipo de tratamiento a prescribir y por lo tanto el tipo de plantilla a fabricar.3. Procedure for obtaining a product for the manufacture of insoles, orthotics and prostheses for feet and footwear, according to previous claims, characterized in that each of the single-use containers is coded differently in order to distinguish the type of additive that it has, indicating to the professional the component to be used according to the type of treatment to be prescribed and therefore the type of template to be manufactured. 4. Procedimiento de obtención de un producto para la fabricación de plantillas, ortesis y prótesis para pies y calzados, según reivindicación 3ª, caracterizado porque la codificación diferente para cada envase de un solo uso, puede opcionalmente estar realizada con un color u otro.4. Procedure for obtaining a product for the manufacture of insoles, orthotics and prostheses for feet and footwear, according to claim 3, characterized in that the different coding for each single-use container can optionally be made with one color or another.
ES200703233A 2007-12-05 2007-12-05 PROCEDURE FOR OBTAINING A PRODUCT FOR THE MANUFACTURE OF TILLAS PLAN, ORTHESIS AND PROTESIS FOR FEET AND SHOES. Expired - Fee Related ES2323627B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES200703233A ES2323627B1 (en) 2007-12-05 2007-12-05 PROCEDURE FOR OBTAINING A PRODUCT FOR THE MANUFACTURE OF TILLAS PLAN, ORTHESIS AND PROTESIS FOR FEET AND SHOES.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200703233A ES2323627B1 (en) 2007-12-05 2007-12-05 PROCEDURE FOR OBTAINING A PRODUCT FOR THE MANUFACTURE OF TILLAS PLAN, ORTHESIS AND PROTESIS FOR FEET AND SHOES.

Publications (2)

Publication Number Publication Date
ES2323627A1 true ES2323627A1 (en) 2009-07-21
ES2323627B1 ES2323627B1 (en) 2010-05-11

Family

ID=40852596

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200703233A Expired - Fee Related ES2323627B1 (en) 2007-12-05 2007-12-05 PROCEDURE FOR OBTAINING A PRODUCT FOR THE MANUFACTURE OF TILLAS PLAN, ORTHESIS AND PROTESIS FOR FEET AND SHOES.

Country Status (1)

Country Link
ES (1) ES2323627B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3103699A1 (en) * 2019-11-29 2021-06-04 Thuasne Device for treating at least one area of the body comprising an orthosis and at least one flexible insert having at least one mechanical function comprising a silicone polymer matrix comprising at least one active principle.

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES259544U (en) * 1980-07-18 1982-01-16 Bayer Aktiengesellschaft Orthopaedic walking heel for foot supporting bandages.
US4524102A (en) * 1984-02-15 1985-06-18 Fritz Hostettler Microcellular polyurethane foams having integral skin
US5088484A (en) * 1990-10-05 1992-02-18 Carolina Narrow Fabric Company Orthopedic casting bandage
EP0945363A1 (en) * 1998-03-21 1999-09-29 B & F Formulier- und Abfüll GmbH Twin-compartment cartridge for producing a 2-components polyurethane foam
US6777524B1 (en) * 1999-08-19 2004-08-17 Asahi Kasei Kabushiki Kaisha Polyether polyurethane
EP1801029A1 (en) * 2005-12-23 2007-06-27 Bafotec GmbH Plastic pouch having two compartments

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES259544U (en) * 1980-07-18 1982-01-16 Bayer Aktiengesellschaft Orthopaedic walking heel for foot supporting bandages.
US4524102A (en) * 1984-02-15 1985-06-18 Fritz Hostettler Microcellular polyurethane foams having integral skin
US5088484A (en) * 1990-10-05 1992-02-18 Carolina Narrow Fabric Company Orthopedic casting bandage
EP0945363A1 (en) * 1998-03-21 1999-09-29 B & F Formulier- und Abfüll GmbH Twin-compartment cartridge for producing a 2-components polyurethane foam
US6777524B1 (en) * 1999-08-19 2004-08-17 Asahi Kasei Kabushiki Kaisha Polyether polyurethane
EP1801029A1 (en) * 2005-12-23 2007-06-27 Bafotec GmbH Plastic pouch having two compartments

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
[en línea] Recuperado de EPO WPI Database [29.06.2009], DW199945, Número de Acceso 1999-530004 & EP 0945363 A1 (B & F FORMULIER UND ABFUELL GM) 29.09.1999, resumen *
[en línea]Recuperado de EPO WPI Database [29.06.2009], DW200751, Número de Acceso 2007-516399 & EP 1801029 A1 (BAFOTEC GMBH) 27.06.2007, resumen, Ver Figura 1. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3103699A1 (en) * 2019-11-29 2021-06-04 Thuasne Device for treating at least one area of the body comprising an orthosis and at least one flexible insert having at least one mechanical function comprising a silicone polymer matrix comprising at least one active principle.

Also Published As

Publication number Publication date
ES2323627B1 (en) 2010-05-11

Similar Documents

Publication Publication Date Title
RU2015154035A (en) METHOD FOR TRANSVERSE SEWING OF HYALURONIC ACID, METHOD FOR PREPARING INJECTION HYDROGEL, HYDROGEL AND ITS APPLICATION
US8979820B2 (en) Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes
ES2323627B1 (en) PROCEDURE FOR OBTAINING A PRODUCT FOR THE MANUFACTURE OF TILLAS PLAN, ORTHESIS AND PROTESIS FOR FEET AND SHOES.
CN106188725A (en) A kind of sole with antibiotic effect
CN102112075A (en) Articles providing refreshing or warming effect to users
US20160045634A1 (en) Analgesic Formulation and Delivery Bandage
CN102462062A (en) Medicine health care insole
US20160143823A1 (en) Bath Salt Composition
KR20100031363A (en) Toe guard for cure and prevention of athlete's foot
KR20160117080A (en) Soluble mask sheet, mask pack for cosmetics, and packaging kit comprising the same
US20130197456A1 (en) Oil Resistant Polymer Device, Method and Kit for Treating Fungal Infected Nail
WO2011124085A1 (en) Healthcare insole with traditional chinese medicine
CN205698175U (en) Set waterproof and breathable multi-functional ankle joint brace
Lee Case reports on 70 Tic disorder cases managed with functional cerebrospinal therapy (FCST)
KR101984953B1 (en) A manufacturing method of functional foods
CN106619946A (en) Traditional Chinese medicine formula for treating tinea pedis
KR20190052276A (en) Soluble mask sheet, mask pack for cosmetics, and packaging kit comprising the same
Day Healthy Living
US52032A (en) Improved medical compound
RU95472U1 (en) HEATING SHOES
KR20230099809A (en) Supplements for the treatment of foot disorders
CN106552000A (en) A kind of formula for controlling chronic vertigo disease
CN101301312A (en) Beriberi medicament and preparation thereof
BR202021009157U2 (en) ARTIFICIAL NAIL
CN106306779A (en) Rose fragrant congee

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20090721

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2323627B1

Country of ref document: ES

PC2A Transfer of patent

Owner name: BIOMECH CONSULTING, S.L.

Effective date: 20160418

FD2A Announcement of lapse in spain

Effective date: 20211119